Concepedia

Róbert Kirschner

RK

Statistics

Publications

16

Citations

1.2K

H-Index

13

Active since

2002

Affiliations

Bayer (Germany)(Current)

Steno Diabetes Centers

University of Copenhagen

University of Groningen

University Medical Center Groningen

Róbert Kirschner is an author at Bayer (Germany) specializing in medicine, pharmacotherapy, and chronic kidney disease.

Publications per year

2002–2025

16

Publications

16

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial

Deepak L. Bhatt, Philippe Gabríel Steg, Shamir R Mehta et al. · The Lancet · 2019 · 210 citations · Full text

Medicine, Cardiology, Pharmacotherapy +15

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 122 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 94 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

HYPOTENSIVE RESUSCITATION OF MULTIPLE HEMORRHAGES USING CRYSTALLOID AND COLLOIDS

Abraham D. Rafie, Paul A. Rath, Michael W Michell et al. · Shock · 2004 · 88 citations

Medicine, Surgery, Emergency Surgery +13

1–5 of 16